<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "cladribine inj VIAL">
<dose><value>0.12</value>
<value>0.09 - 0.1</value>
<value>8</value>
<value>3.4</value>
<value>1.5</value>
<value>0.1</value>
<value>0.14</value>
</dose>
<route><value>IV</value>
<value>SC</value>
</route>
<strength><value>1 mg/mL</value>
</strength>
<frequency><value>DAILY</value>
<value>CONTINUOUS</value>
<value>TID</value>
</frequency>
<instruction><value>for 5 days. Administer dose over 2 hours.</value>
<value>for 7 consecutive days. Administer by continuous infusion.</value>
<value>for 7 days.</value>
<value>for 5 days.</value>
</instruction>
<volume><value>10 mL</value>
</volume>
<units><value>mg/kg</value>
<value>mg/kg/day</value>
<value>mg/m2</value>
</units>
<Population><value>ADULT</value>
<value>PEDIATRIC</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Hairy Cell Leukemia</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3358</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>